By Rose Krebs ( January 14, 2019, 2:59 PM EST) -- A Delaware bankruptcy judge on Monday approved pharmaceutical company Egalet Corp.'s Chapter 11, just a little more than two months after the company entered bankruptcy citing shifts in the abuse-deterrent drug market and announcing plans to acquire four anti-inflammatory drugs from another company to boost revenue....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.